Formula Growth’s MarineMax HZO Stock Holding History

Formula Growth’s Portfolio HZO Stock Details HZO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-46,696	Closed	-$909K	–	156
2016 Q1	$909K	Buy	46,696 +9,039	+24%	+$155K	0.22%	121
2015 Q4	$694K	Buy	+37,657	New	+$626K	0.16%	137

Other funds holding HZO

CIP

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

IAM

Impala Asset Management Palm Beach, Florida $176M AUM 44.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Formula Growth's HZO Position: Q2 2016 in Review

Formula Growth sold out of MarineMax (HZO) in Q2 2016, closing a stake of 46,696 shares — an estimated $909K sold.

Formula Growth first reported a position in HZO in Q4 2015 and held it in 2 quarters. The position peaked at $909K in Q1 2016. 134 funds tracked by Wall St. Rank hold HZO as of Q2 2016.

Formula Growth reported no remaining MarineMax position as of Q2 2016 after selling out during the quarter.
Formula Growth sold 46,696 MarineMax shares in Q2 2016, an estimated $909K.
Formula Growth first reported a position in MarineMax in Q4 2015 and held it in 2 quarters.
Formula Growth's MarineMax position peaked at $909K in Q1 2016.
134 funds tracked by Wall St. Rank held MarineMax as of Q2 2016.

Based on Formula Growth's 13F filing for Q2 2016, filed 15 Aug 2016.